Does the POS-DemA improve dementia care in Swiss nursing homes
At a glance
- Project leader : Prof. Dr. Andrea Luise Koppitz
- Co-project leader : Prof. Dr. Fliss Murthagh
- Project team : Susanne de Wolf-Linder
- Project status : completed
- Funding partner : Foundation (Gottfried und Julia Bangerter-Rhyner-Stiftung)
- Project partner : King’s College London, Ludwig-Maximilians-Universität München LMU, Hull York Medical School
- Contact person : Maria Schubert
50% of nursing home residents are suffering from dementia (PwD) including other co-morbidities, which may lead to uncontrolled symptom burden. A comprehensive symptom assessment in order to avoid symptoms being ignored or misinterpreted, is difficult to conduct due to memory deficits and communication barriers. Only a few adequate comprehensive assessment tools for PwD are available.
- To reduce the symptom severity in PwD by using the IPOS-Dem (Integrated Palliative Outcome Scale).
- To provide tailored care in line with the symptom severity measured with the IPOS-Dem.
Research Question: Does the implementation of the IPOS-Dem intervention reduce severity of symptoms in people with dementia in nursing homes?
Methods:Stepped-Wedged Cluster Randomised Controlled Trial
3. Nationale Fachtagung GERONTOLOGIE CH, Fribourg, Schweiz, 6. September 2022.
National Research Day Palliative Care, Bern, Switzerland, 25 August 2022.
Koppitz, Andrea Luise; de Wolf-Linder, Susanne; Spichiger, Frank; Volken, Thomas; Murthag, F.E.M.,
SAMW-Symposium, Bern, 21. November 2019.